Eris Lifesciences Limited (BSE:540596) is looking for acquisitions. Krishnakumar Vaidyanathan, Executive Director & Chief Operating Officer said "So as of September, we had INR 5,190 million of cash balance. So the capital project that is coming up, that has an outlay of around INR 1,500 million.

We have also been actively evaluating acquisitions and in-licensing opportunities. So there are some opportunities in the pipeline at all times".